Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...
Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy counter in 2025.   “That $2,000 cap,” which will be adjusted annually for ...
A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation’s nearly 55 million Medicare drug plan enrollees. For the first time ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...